Exelixis
EXEL
#1814
Rank
NZ$19.01 B
Marketcap
NZ$70.91
Share price
-1.36%
Change (1 day)
11.57%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company